Nephrotic Syndrome and Posterior Reversible Encephalopathy Syndrome as Clinical Presentations of Gemcitabine-Induced Thrombotic Micro-Angiopathy

被引:1
|
作者
Jha, Vijoy Kumar [1 ,5 ]
Akal, Ramanjit Singh [1 ]
Mahapatra, Debasish [1 ]
Sharma, Alok [2 ]
Singh, Bhanu Pratap [3 ]
Arora, Rahil [4 ]
机构
[1] Command Hosp Air Force, Dept Nephrol, Bengaluru, Karnataka, India
[2] Lal PathLabs Ltd, Renal Pathol & Electron Microscopy, New Delhi, India
[3] Command Hosp Air Force, Dept Radiol, Bengaluru, Karnataka, India
[4] Command Hosp Air Force, Dept Med, Bengaluru, Karnataka, India
[5] Command Hosp Air Force, Bangalore 560007, Karnataka, India
关键词
Gemcitabine; nephrotic syndrome; PRES; TMA; HEMOLYTIC-UREMIC SYNDROME; MICROANGIOPATHY; CHEMOTHERAPY; CANCER;
D O I
10.4103/ijn.ijn_277_22
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Gemcitabine-induced thrombotic micro-angiopathy (GiTMA) is a very rare pathology of micro-vascular occlusion with a poor prognosis. In this case report, we present a young male with pancreatic carcinoma who received gemcitabine as adjuvant chemotherapy and developed thrombotic micro-angiopathy (TMA) manifesting as nephrotic syndrome with renal dysfunction and posterior reversible encephalopathy syndrome (PRES). The case was successfully managed with discontinuation of the drug and conservative management. The pathogenesis of GiTMA might be direct endothelial dysfunction with consequent activation of the clotting system. The role of plasma exchanges and monoclonal antibodies is unclear in drug-induced TMA.
引用
收藏
页码:74 / 78
页数:5
相关论文
共 50 条
  • [21] Posterior Reversible Encephalopathy Syndrome (PRES) in 5-year-old girl with nephrotic syndrome
    Kabicek, Pavel
    Sulek, Stepan
    Seidl, Zdenek
    Vaneckova, Manuela
    Kabickova, Edita
    Vobruba, Vaclav
    Wenchich, Laszlo
    Zeman, Jiri
    NEUROENDOCRINOLOGY LETTERS, 2010, 31 (03) : 297 - 300
  • [22] Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome
    Khajuria, Bhavik
    Khajuria, Mansi
    Agrawal, Yashwant
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (04) : E1072 - E1073
  • [23] Bortezomib-induced Posterior Reversible Encephalopathy Syndrome: Clinical and Imaging Features
    Ho, Chien-Hui
    Lo, Chung-Ping
    Tu, Min-Chien
    INTERNAL MEDICINE, 2014, 53 (16) : 1853 - 1857
  • [24] Cyclophosphamide-induced posterior reversible encephalopathy syndrome: A case report
    Shrestha, Gentle S.
    Nepal, Gaurav
    Basnet, Babin
    Bhandari, Sandip
    Poudyal, Bishesh S.
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (04): : 349 - 352
  • [25] Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin
    R. Dersch
    O. Stich
    K. Goller
    S. Meckel
    F. Dechent
    S. Doostkam
    C. Weiller
    J. Bardutzky
    Journal of Neurology, 2013, 260 : 1406 - 1407
  • [26] Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin
    Dersch, R.
    Stich, O.
    Goller, K.
    Meckel, S.
    Dechent, F.
    Doostkam, S.
    Weiller, C.
    Bardutzky, J.
    JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1406 - 1407
  • [27] Clinical profile and outcome of posterior reversible encephalopathy syndrome (PRES)
    Patil, Virendra C.
    Agrwal, Vaibhav
    Rajput, Amardip
    Garg, Rishu
    Kshirsagar, Ketan
    Chaudhari, Vinit
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 8 (04) : 105 - 112
  • [28] Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome?
    Li, Richard
    Mitchell, Peter
    Dowling, Richard
    Yan, Bernard
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (02) : 242 - 246
  • [29] Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome
    della Faille, Laetitia
    Fieuws, S.
    Van Paesschen, W.
    ACTA NEUROLOGICA BELGICA, 2017, 117 (02) : 469 - 475
  • [30] Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome
    Laetitia della Faille
    S. Fieuws
    W. Van Paesschen
    Acta Neurologica Belgica, 2017, 117 : 469 - 475